Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2005 4
2006 2
2007 1
2008 1
2009 4
2010 4
2011 3
2012 2
2013 3
2015 1
2016 2
2017 2
2018 9
2019 7
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

46 results
Results by year
Filters applied: . Clear all
Page 1
Antiproliferative evaluation of various aminoquinoline derivatives.
Zorc B, Rajić Z, Perković I. Zorc B, et al. Acta Pharm. 2019 Dec 1;69(4):661-672. doi: 10.2478/acph-2019-0048. Acta Pharm. 2019. PMID: 31639093
Primaquine derivatives: Modifications of the terminal amino group.
Zorc B, Perković I, Pavić K, Rajić Z, Beus M. Zorc B, et al. Eur J Med Chem. 2019 Nov 15;182:111640. doi: 10.1016/j.ejmech.2019.111640. Epub 2019 Aug 23. Eur J Med Chem. 2019. PMID: 31472472 Free PMC article. Review.
Second generation of primaquine ureas and bis-ureas as potential antimycobacterial agents.
Pavić K, Rajić Z, Michnová H, Jampílek J, Perković I, Zorc B. Pavić K, et al. Among authors: zorc b. Mol Divers. 2019 Aug;23(3):657-667. doi: 10.1007/s11030-018-9899-z. Epub 2018 Dec 6. Mol Divers. 2019. PMID: 30523579
Chloroquine Urea Derivatives: Synthesis and Antitumor Activity in Vitro.
Rajić KPZ, Mlinarić Z, Uzelac L, Kralj M, Zorc B. Rajić KPZ, et al. Among authors: zorc b. Acta Pharm. 2018 Dec 1;68(4):471-483. doi: 10.2478/acph-2018-0039. Acta Pharm. 2018. PMID: 31259711
Synthesis and antiplasmodial evaluation of novel mefloquine-based fumardiamides.
Beus M, Fontinha D, Held J, Rajić Z, Prudêncio M, Zorc B. Beus M, et al. Among authors: zorc b. Acta Pharm. 2019 Jun 1;69(2):233-248. doi: 10.2478/acph-2019-0019. Acta Pharm. 2019. PMID: 31259728
Insights into biological activity of ureidoamides with primaquine and amino acid moieties.
Vlainić J, Kosalec I, Pavić K, Hadjipavlou-Litina D, Pontiki E, Zorc B. Vlainić J, et al. Among authors: zorc b. J Enzyme Inhib Med Chem. 2018 Dec;33(1):376-382. doi: 10.1080/14756366.2017.1423067. J Enzyme Inhib Med Chem. 2018. PMID: 29363364 Free PMC article.
Asymmetric Primaquine and Halogenaniline Fumardiamides as Novel Biologically Active Michael Acceptors.
Rajić Z, Beus M, Michnová H, Vlainić J, Persoons L, Kosalec I, Jampílek J, Schols D, Keser T, Zorc B. Rajić Z, et al. Among authors: zorc b. Molecules. 2018 Jul 14;23(7):1724. doi: 10.3390/molecules23071724. Molecules. 2018. PMID: 30011922 Free PMC article.
Machine learning prioritizes synthesis of primaquine ureidoamides with high antimalarial activity and attenuated cytotoxicity.
Levatić J, Pavić K, Perković I, Uzelac L, Ester K, Kralj M, Kaiser M, Rottmann M, Supek F, Zorc B. Levatić J, et al. Among authors: zorc b. Eur J Med Chem. 2018 Feb 25;146:651-667. doi: 10.1016/j.ejmech.2018.01.062. Epub 2018 Jan 31. Eur J Med Chem. 2018. PMID: 29407988
Primaquine and Chloroquine Fumardiamides as Promising Antiplasmodial Agents.
Beus M, Fontinha D, Held J, Rajić Z, Uzelac L, Kralj M, Prudêncio M, Zorc B. Beus M, et al. Among authors: zorc b. Molecules. 2019 Aug 1;24(15):2812. doi: 10.3390/molecules24152812. Molecules. 2019. PMID: 31374989 Free PMC article.
46 results
Jump to page
Feedback